Eli Lilly has begun a Phase 3 trial testing whether an experimental antibody drug can prevent either coronavirus infections or COVID-19 in nursing home residents or staff who have been exposed to someone diagnosed with the disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,